全文获取类型
收费全文 | 1672篇 |
免费 | 142篇 |
国内免费 | 16篇 |
专业分类
耳鼻咽喉 | 26篇 |
儿科学 | 84篇 |
妇产科学 | 45篇 |
基础医学 | 203篇 |
口腔科学 | 51篇 |
临床医学 | 187篇 |
内科学 | 329篇 |
皮肤病学 | 17篇 |
神经病学 | 62篇 |
特种医学 | 241篇 |
外科学 | 150篇 |
综合类 | 57篇 |
一般理论 | 1篇 |
预防医学 | 187篇 |
眼科学 | 9篇 |
药学 | 63篇 |
中国医学 | 1篇 |
肿瘤学 | 117篇 |
出版年
2021年 | 14篇 |
2018年 | 14篇 |
2017年 | 17篇 |
2016年 | 16篇 |
2015年 | 18篇 |
2014年 | 22篇 |
2013年 | 40篇 |
2012年 | 51篇 |
2011年 | 57篇 |
2010年 | 43篇 |
2009年 | 50篇 |
2008年 | 46篇 |
2007年 | 56篇 |
2006年 | 53篇 |
2005年 | 44篇 |
2004年 | 40篇 |
2003年 | 56篇 |
2002年 | 38篇 |
2001年 | 35篇 |
2000年 | 48篇 |
1999年 | 38篇 |
1998年 | 56篇 |
1997年 | 61篇 |
1996年 | 49篇 |
1995年 | 31篇 |
1994年 | 44篇 |
1993年 | 42篇 |
1992年 | 38篇 |
1991年 | 34篇 |
1990年 | 29篇 |
1989年 | 60篇 |
1988年 | 35篇 |
1987年 | 40篇 |
1986年 | 51篇 |
1985年 | 39篇 |
1984年 | 31篇 |
1983年 | 37篇 |
1982年 | 26篇 |
1981年 | 44篇 |
1980年 | 17篇 |
1979年 | 22篇 |
1978年 | 20篇 |
1977年 | 20篇 |
1976年 | 18篇 |
1975年 | 20篇 |
1972年 | 14篇 |
1969年 | 12篇 |
1968年 | 14篇 |
1966年 | 15篇 |
1920年 | 12篇 |
排序方式: 共有1830条查询结果,搜索用时 15 毫秒
81.
82.
83.
Wheat-germ agglutination of Neisseria gonorrhoeae. A laboratory investigation. 总被引:4,自引:0,他引:4 下载免费PDF全文
Wheat-germ agglutination (WGA) was used to identify 168 strains of Neisseria gonorrhoeae and 105 strains of other Neisseria species in a routine laboratory. About one-third of the meningococci reacted with the lectin and titres with some organisms varied on repeat testing. The technique is regarded as unreliable for the identification of Neisseria species. 相似文献
84.
LeRoy AJ; Williams HJ Jr; Bender CE; Segura JW; Patterson DE; Benson RC 《Radiology》1985,155(1):83-85
Two patients had colonic perforation as a result of percutaneous nephrostomy placement followed by track dilatation and renal calculus removal. We present the technical aspects of nephrostomy placement and stone removal, as well as the clinical diagnosis and management of these cases. Both patients recovered well with conservative therapy and required no surgical intervention. This report reviews the anatomic considerations for percutaneous nephrostomy in patients undergoing renal stone removal. 相似文献
85.
86.
R W Slack 《The British journal of surgery》1975,62(12):963-965
The Cancer Register for the South-West Region of England has been used to examine the survival rate of men with carcinoma of the breast, and a comparison has been made with carcinoma of the breast in women. For all men with carcinoma of the breast the prognosis is worse than for all women, but comparing the prognosis by clinical stage, the difference between men and women is small. However, the survival rate in men under 65 years of age is appreciably better than for men over 65, and for older men the survival rate is considerably less than for women over 65. 相似文献
87.
Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence 总被引:3,自引:0,他引:3
88.
Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma 总被引:5,自引:0,他引:5
Retinogenesis involves expansion of pluripotent progenitors, specification of postmitotic precursors, and terminal differentiation. Rb or Rb/p107 loss causes retinoblastoma in humans or mice, respectively. One model suggests that Rb- or Rb/p107-deficient retinal precursors have infinite proliferative capacity but are death-prone and must acquire an antiapoptotic mutation. Indeed, we show that Rb/p107 loss does not affect progenitor proliferation or precursor specification, but perturbs cell cycle exit in all seven retinal precursors. However, three precursors survive Rb/p107-loss and stop proliferating following terminal differentiation. Tumors arise from precursors that escape this delayed growth arrest. Thus, retinoblastoma arises from a precursor that has extended, not infinite, proliferative capacity, and is intrinsically death-resistant, not death-prone. We suggest that additional lesions common in retinoblastoma overcome growth arrest, not apoptosis. 相似文献
89.
Freeman R Hill S Millard R Slack M Sutherst J;Tolterodine Study Group 《Obstetrics and gynecology》2003,102(3):605-611
OBJECTIVE: To evaluate the effect of once-daily, extended-release tolterodine on urinary urgency in patients with overactive bladder. METHODS: Patients with urinary frequency (eight or more micturitions per 24 hours) and urge incontinence (five or more episodes per week) were randomized to oral treatment with tolterodine extended release 4 mg once daily (n=398) or placebo (n=374) for 12 weeks. Efficacy was assessed by use of patient perception evaluations. RESULTS: The results presented are a secondary analysis of this double-blind, placebo-controlled study. Of patients treated with tolterodine extended release, 44% reported improved urgency symptoms (compared with 32% for placebo), and 62% reported improved bladder symptoms (placebo, 48%) (both P<.001 compared with placebo). The odds of reducing urgency and improving bladder symptoms were 1.68 and 1.78 times greater, respectively, for patients in the tolterodine extended release group than for patients receiving placebo. In response to urgency, there was a more than six-fold increase in the proportion of patients able to finish a task before voiding in the tolterodine extended release group. The proportion of patients unable to hold urine upon experiencing urgency was also decreased by 58% with tolterodine, compared with 32% with placebo (P<.001). The proportion of patients reporting "much benefit" from treatment was greater for tolterodine extended release than for placebo (43% versus 24%; P<.001). The only adverse events with an incidence of greater than 5% were dry mouth, headache, and constipation, with only dry mouth markedly more frequent with tolterodine than with placebo. CONCLUSION: Tolterodine extended release has demonstrable efficacy in reducing the severity of urinary urgency and is associated with improvements in overactive bladder symptoms that are meaningful to patients. 相似文献
90.
Ramsay ME McVernon J Andrews NJ Heath PT Slack MP 《The Journal of infectious diseases》2003,188(4):481-485
In October 1992, Haemophilus influenzae type b (Hib) conjugate vaccine was introduced to infants in the United Kingdom with a "catch-up" program for those aged <4 years. Initially, the rate of invasive Hib disease decreased dramatically but has been increasing since 1999. To determine possible reasons for this increase, the effectiveness of Hib conjugate vaccine was estimated by use of the screening method. Between October 1993 and December 2001, a total of 443 cases of Hib infection occurred in children eligible for vaccination; 363 (82%) were fully vaccinated. Vaccine effectiveness was estimated to be 56.7% (95% confidence interval, 42.5-67.4). Effectiveness was lower in children vaccinated during infancy, compared with those who were vaccinated during the catch-up campaign (P=.0033), declined with time since vaccination (P=.0008), and was lower in children born during 2000-2002, compared with other children scheduled for infant vaccination (P=.0041). Use of a catch-up vaccination program enhanced the control of Hib infection in England and Wales. Since 1999, however, low effectiveness in infants, declining effectiveness with age, and the use of lower-efficacy vaccines have contributed to increased rates of Hib infection. The potential role of boosters needs to be considered. 相似文献